The Patient Ratings and comments are gathered from our Patient Satisfaction Survey and displayed in their entirety.
Stay Connected. Manage Your Care.
Access your health information anytime and anywhere, at home or on the go, with MyHealth.
- Message your clinic
- View your lab results
- Schedule your next appointment
- Pay your bill
The MyHealth mobile app from Stanford Health Care puts all your health information at your fingertips and makes managing your health care simple and quick.
Guest Services
24/7
We are available to assist you
whenever you need it. Give us a call at
650-498-3333 or
PHYSICIAN HELPLINE
Have a question? We're here to help! Call 1-866-742-4811
Monday - Friday, 8 a.m. - 5 p.m.
REFER A PATIENT
Fax 650-320-9443
Track your patients' progress and communicate with Stanford providers conveniently and securely.
Elizabeth Kidd
Radiation oncologist
Practice Areas
Professional Education
- Residency: Washington University Dept of Radiation Oncology (2010) MO
- Internship: Washington University School Of Medicine (2006) MO
- Medical Education: Washington University School Of Medicine (2005) MO
- Board Certification: Radiation Oncology, American Board of Radiology (2011)
Publications
-
Impact of socioeconomic status and ethnic enclave on cervical cancer incidence among Hispanics and Asians in California
Froment, M.-A., Gomez, S. L., Roux, A., DeRouen, M. C., & Kidd, E. A. (2014). Impact of socioeconomic status and ethnic enclave on cervical cancer incidence among Hispanics and Asians in California. GYNECOLOGIC ONCOLOGY, 133(3), 409-415. -
Impact of Chemotherapy on Normal Tissue Complication Probability Models of Acute Hematologic Toxicity in Patients Receiving Pelvic Intensity Modulated Radiation Therapy
Bazan, J. G., Luxton, G., Kozak, M. M., Anderson, E. M., Hancock, S. L., & Chang, D. T. (2013). Impact of Chemotherapy on Normal Tissue Complication Probability Models of Acute Hematologic Toxicity in Patients Receiving Pelvic Intensity Modulated Radiation Therapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 87(5), 983-991. -
ACR APPROPRIATENESS CRITERIA (R) Management of Vaginal Cancer
Lee, L. J., Jhingran, A., Kidd, E., Cardenes, H. R., Elshaikh, M. A., & Gaffney, D. K. (2013). ACR APPROPRIATENESS CRITERIA (R) Management of Vaginal Cancer. ONCOLOGY-NEW YORK, 27(11), 1166-1173. -
Primary squamous cell carcinoma of the vagina: Prognostic factors, treatment patterns, and outcomes
Hiniker, S. M., Roux, A., Murphy, J. D., Harris, J. P., Tran, P. T., & Kidd, E. A. (2013). Primary squamous cell carcinoma of the vagina: Prognostic factors, treatment patterns, and outcomes. GYNECOLOGIC ONCOLOGY, 131(2), 380-385.
-
Treatment Approach and Outcomes of Vaginal Melanoma
Kirschner, A. N., Kidd, E. A., Dewees, T., & Perkins, S. M. (2013). Treatment Approach and Outcomes of Vaginal Melanoma. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 23(8), 1484-1489.
-
ACR Appropriateness Criteria (R) Management of Locoregionally Advanced Squamous Cell Carcinoma of the Vulva
Kidd, E., Moore, D., Varia, M. A., Gaffney, D. K., Elshaikh, M. A., & Cardenes, H. R. (2013). ACR Appropriateness Criteria (R) Management of Locoregionally Advanced Squamous Cell Carcinoma of the Vulva. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 36(4), 415-422.
-
Changes in Cervical Cancer FDG Uptake During Chemoradiation and Association With Response
Kidd, E. A., Thomas, M., Siegel, B. A., Dehdashti, F., & Grigsby, P. W. (2013). Changes in Cervical Cancer FDG Uptake During Chemoradiation and Association With Response. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 85(1), 116-122.
-
FDG-PET-based prognostic nomograms for locally advanced cervical cancer
Kidd, E. A., El Naqa, I., Siegel, B. A., Dehdashti, F., & Grigsby, P. W. (2012). FDG-PET-based prognostic nomograms for locally advanced cervical cancer. GYNECOLOGIC ONCOLOGY, 127(1), 136-140.
-
ACR Appropriateness Criteria (R) Definitive Therapy for Early-Stage Cervical Cancer
Small, W., Strauss, J. B., Jhingran, A., Yashar, C. M., Cardenes, H. R., & Gaffney, D. K. (2012). ACR Appropriateness Criteria (R) Definitive Therapy for Early-Stage Cervical Cancer. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 35(4), 399-405.
-
RADIATION THERAPY FOR PILOCYTIC ASTROCYTOMAS OF CHILDHOOD
Mansur, D. B., Rubin, J. B., Kidd, E. A., King, A. A., Hollander, A. S., & Leonard, J. R. (2011). RADIATION THERAPY FOR PILOCYTIC ASTROCYTOMAS OF CHILDHOOD. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 79(3), 829-834.
-
CLINICAL OUTCOMES OF DEFINITIVE INTENSITY-MODULATED RADIATION THERAPY WITH FLUORODEOXYGLUCOSE-POSITRON EMISSION TOMOGRAPHY SIMULATION IN PATIENTS WITH LOCALLY ADVANCED CERVICAL CANCER
Kidd, E. A., Siegel, B. A., Dehdashti, F., Rader, J. S., Mutic, S., & Grigsby, P. W. (2010). CLINICAL OUTCOMES OF DEFINITIVE INTENSITY-MODULATED RADIATION THERAPY WITH FLUORODEOXYGLUCOSE-POSITRON EMISSION TOMOGRAPHY SIMULATION IN PATIENTS WITH LOCALLY ADVANCED CERVICAL CANCER. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 77(4), 1085-1091.
-
Anal cancer maximum F-18 fluorodeoxyglucose uptake on positron emission tomography is correlated with prognosis
Kidd, E. A., Dehdashti, F., Siegel, B. A., & Grigsby, P. W. (2010). Anal cancer maximum F-18 fluorodeoxyglucose uptake on positron emission tomography is correlated with prognosis. RADIOTHERAPY AND ONCOLOGY, 95(3), 288-291.
-
Lymph Node Staging by Positron Emission Tomography in Cervical Cancer: Relationship to Prognosis
Kidd, E. A., Siegel, B. A., Dehdashti, F., Rader, J. S., Mutch, D. G., & Grigsby, P. W. (2010). Lymph Node Staging by Positron Emission Tomography in Cervical Cancer: Relationship to Prognosis. JOURNAL OF CLINICAL ONCOLOGY, 28(12), 2108-2113.
-
Pelvic Lymph Node F-18 Fluorodeoxyglucose Uptake as a Prognostic Biomarker in Newly Diagnosed Patients With Locally Advanced Cervical Cancer
Kidd, E. A., Siegel, B. A., Dehdashti, F., & Grigsby, P. W. (2010). Pelvic Lymph Node F-18 Fluorodeoxyglucose Uptake as a Prognostic Biomarker in Newly Diagnosed Patients With Locally Advanced Cervical Cancer. CANCER, 116(6), 1469-1475.
-
Cervical Cancer Histology and Tumor Differentiation Affect F-18-Fluorodeoxyglucose Uptake
Kidd, E. A., Spencer, C. R., Huettner, P. C., Siegel, B. A., Dehdashti, F., & Grigsby, P. W. (2009). Cervical Cancer Histology and Tumor Differentiation Affect F-18-Fluorodeoxyglucose Uptake. CANCER, 115(15), 3548-3554.
-
Exploring feature-based approaches in PET images for predicting cancer treatment outcomes.
El Naqa, I., Grigsby, P., Apte, A., Kidd, E., Donnelly, E., & Deasy, J. O. (2009). Exploring feature-based approaches in PET images for predicting cancer treatment outcomes. Pattern recognition, 42(6), 1162-1171.
-
Intratumoral metabolic heterogeneity of cervical cancer
Kidd, E. A., & Grigsby, P. W. (2008). Intratumoral metabolic heterogeneity of cervical cancer. CLINICAL CANCER RESEARCH, 14(16), 5236-5241.
-
The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival
Kidd, E. A., Siegel, B. A., Dehdashti, F., & Grigsby, P. W. (2007). The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival. CANCER, 110(8), 1738-1744.
-
The efficacy of radiation therapy in the management of grade I astrocytomas
Kidd, E. A., Mansur, D. B., Leonard, J. R., Michalski, J. M., Simpson, J. R., & Perry, A. (2006). The efficacy of radiation therapy in the management of grade I astrocytomas. JOURNAL OF NEURO-ONCOLOGY, 76(1), 55-58.
-
Variance in the expression of 5-fluorouracil pathway genes in colorectal cancer
Kidd, E. A., Yu, J. S., Li, X., Shannon, W. D., Watson, M. A., & McLeod, H. L. (2005). Variance in the expression of 5-fluorouracil pathway genes in colorectal cancer. CLINICAL CANCER RESEARCH, 11(7), 2612-2619.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Patient Comments
Patients comments are gathered from our Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
SHC Patient, Sep 2015
Dr. Kidd is the best.
SHC Patient, Jul 2015
She entirely failed to share important information. Patients have to be informed.
SHC Patient, Jun 2015
Highly recommended!
SHC Patient, Jun 2015
Even though I know Dr. Kidd is very busy and has lots of patients to attend to, I really appreciate the fact that she takes a little time to ask me if I have any travel plans. That's nice!
SHC Patient, Jun 2015
Truly a good person for me.
SHC Patient, May 2015
Very good they were excellent people.
SHC Patient, Feb 2015
Very friendly made me feel comfortable and relaxed and confident.
SHC Patient, Dec 2014
All good and kind to other like me.
SHC Patient, Oct 2014
Expert at inserting IV.
SHC Patient, Aug 2014
Always go away informed and happy.
SHC Patient, Sep 2015
Dr. Kidd is the best.
SHC Patient, Jul 2015
She entirely failed to share important information. Patients have to be informed.
SHC Patient, Jun 2015
Highly recommended!
SHC Patient, Jun 2015
Even though I know Dr. Kidd is very busy and has lots of patients to attend to, I really appreciate the fact that she takes a little time to ask me if I have any travel plans. That's nice!
SHC Patient, Jun 2015
Truly a good person for me.
SHC Patient, May 2015
Very good they were excellent people.
SHC Patient, Feb 2015
Very friendly made me feel comfortable and relaxed and confident.
SHC Patient, Dec 2014
All good and kind to other like me.
SHC Patient, Oct 2014
Expert at inserting IV.
SHC Patient, Aug 2014
Always go away informed and happy.